Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
Intern Med
; 62(22): 3299-3303, 2023 Nov 15.
Article
in En
| MEDLINE
| ID: mdl-37005261
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pleural Effusion
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Dasatinib
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
Language:
En
Journal:
Intern Med
Journal subject:
MEDICINA INTERNA
Year:
2023
Type:
Article
Affiliation country:
Japan